Investor Overview
News
- Kindred Biosciences Announces First Quarter 2021 Financial ResultsMay 11, 2021 4:03 PM EDT
- Kindred Biosciences to Announce First Quarter 2021 Financial ResultsMay 3, 2021 8:42 AM EDT
- Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy IndicationApril 28, 2021 8:32 AM EDT
Events
- Tuesday, May 11, 2021 4:30 PM EDT
- Tuesday, March 16, 2021 4:30 PM EDT
- Wednesday, March 10, 2021 from 2:25 PM to 2:50 PM EST
|
||||||||||||||||
KindredBio proudly supports
Rabies Free Africa
Investor Overview
Kindred Biosciences' First Quarter 2021 Financial Results
Tuesday, May 11, 2021 4:30 PM EDT
KindredBio is focused on bringing innovative biologics and technologies to veterinary medicine to address unmet clinical needs and provide benefits to pets.
Stock Information
News
Kindred Biosciences Announces First Quarter 2021 Financial Results
May 11, 2021
SAN FRANCISCO , May 11, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
Kindred Biosciences to Announce First Quarter 2021 Financial Results
May 3, 2021
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P...
Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy Indication
April 28, 2021
USDA approves the claim that the product is effective for the passive immunizatio...